ENERGIZE THE FIGHT.
Our Mito Champions
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Need to Connect with Us?
Call the Support Line: (888) 900-6486
Ask the Mito Doc – November 2024; Q&A
Ask the Mito Doc - November 2024 Q&A All answers today are based on personal experience of the participants. As always, please consult your personal physician prior to taking any action.Understanding POLG DisordersUnderstanding POLG Disorders: A Dual...
The Mito Fund Announces Investment in Khondrion to Support Development of One of the Most Advanced Drug Candidates for Primary Mitochondrial Disease
The United Mitochondrial Disease Foundation’s (UMDF) venture philanthropy arm, The Mito Fund, has invested in Khondrion, a Netherlands-based clinical stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial disease (PMD)....
UMDF Cosigns Letter to Congress Encouraging End-of-Year Rare Disease Legislative Priorities
UMDF Cosigns Letter to Congress Encouraging End-of-Year Action on Accelerating Kids’ Access to Care Act, Rare Pediatric Disease Priority Review Voucher Program, and More






